No Data
No Data
The first real-world research standards in the health food Industry have been released, and By-health Co., Ltd. is the first to conduct real-world research on products.
Guangzhou, February 28, 2025 /PR Newswire/ -- On February 28, the China Nutrition and Health Food Association officially released the industry's first real-world research standard — "Guidelines for Real-World Research on Health Food." This standard was primarily drafted by the School of Public Health at Sun Yat-sen University, the China National Institute of Standardization, the Health Food R&D Professional Committee of the China Nutrition and Health Food Association, and By-health Co., Ltd. It took three years to develop. It references the real-world research system in the pharmaceutical field and aims to provide scientific methods and technical guidance for the evaluation of the functions and safety of health foods after they are marketed, filling a gap in the industry in this area.
By-health Co., Ltd. (300146.SZ): Obtained a commitment letter for share buyback loans from financial institutions.
On February 26, Gelonghui reported that By-health Co., Ltd. (300146.SZ) announced that it has recently received a "Financing Commitment Letter" issued by the Guangzhou branch of the Industrial And Commercial Bank Of China, with the main contents as follows: 1. Loan amount: not exceeding 180 million yuan; 2. Loan term: not exceeding 36 months; 3. Purpose of the loan: specifically for repurchasing the company's Stocks; 4. Validity period of the commitment letter: 1 year from the date of issuance.
By-health Co., Ltd. (300146.SZ): First repurchase of 0.888 million shares.
On February 6, Gelonghui reported that By-health Co., Ltd. (300146.SZ) announced that on February 5, 2025, the company first implemented this repurchase through a special securities repurchase account via centralized bidding, repurchasing a total of 888,000 shares, accounting for 0.0522% of the company's total share capital, with a highest Fill Price of 11.28 yuan/share, a lowest Fill Price of 11.23 yuan/share, and a total payment amount of 9,993,993.00 yuan (excluding transaction fees). This repurchase complies with relevant laws and regulations and aligns with the company's established repurchase plan.
Express News | By-health Co., Ltd.: Net profit for 2024 is expected to decline by 55.33% to 68.51% year-on-year.
Tomson Beijian: 2024 Annual Results Forecast
The ten worst-performing consumer leaders of 2024.
Survival is the fundamental principle.